Literature DB >> 26494648

Quantifying FDG uptake to diagnose cardiac device infections: When and how should we do it?

Ron Blankstein1,2, Edward J Miller3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26494648     DOI： 10.1007/s12350-015-0293-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  9 in total

1.  Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.

Authors:  María N Pizzi; Albert Roque; Nuria Fernández-Hidalgo; Hug Cuéllar-Calabria; Ignacio Ferreira-González; María T Gonzàlez-Alujas; Gerard Oristrell; Laura Gracia-Sánchez; Juan J González; José Rodríguez-Palomares; Manuel Galiñanes; Olga Maisterra-Santos; David Garcia-Dorado; Joan Castell-Conesa; Benito Almirante; Santiago Aguadé-Bruix; Pilar Tornos
Journal:  Circulation       Date:  2015-08-14       Impact factor: 29.690

2.  Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections.

Authors:  Jean-François Sarrazin; François Philippon; Michel Tessier; Jean Guimond; Franck Molin; Jean Champagne; Isabelle Nault; Louis Blier; Maxime Nadeau; Lyne Charbonneau; Mikaël Trottier; Gilles O'Hara
Journal:  J Am Coll Cardiol       Date:  2012-05-01       Impact factor: 24.094

3.  Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases.

Authors:  Sylvain Ploux; Annalisa Riviere; Sana Amraoui; Zachary Whinnett; Laurent Barandon; Stephane Lafitte; Philippe Ritter; Georgios Papaioannou; Jacques Clementy; Pierre Jais; Laurence Bordenave; Michel Haissaguerre; Pierre Bordachar
Journal:  Heart Rhythm       Date:  2011-04-02       Impact factor: 6.343

4.  Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Alfonso H Waller; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2014-06-19       Impact factor: 5.952

5.  Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.

Authors:  Azadeh Ahmadian; Ashley Brogan; Jeffrey Berman; Aaron L Sverdlov; Gustavo Mercier; Michael Mazzini; Praveen Govender; Frederick L Ruberg; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2014-05-31       Impact factor: 5.952

6.  Role of ¹⁸F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study.

Authors:  Maddalena Graziosi; Cristina Nanni; Massimiliano Lorenzini; Igor Diemberger; Rachele Bonfiglioli; Ferdinando Pasquale; Matteo Ziacchi; Mauro Biffi; Cristian Martignani; Michele Bartoletti; Fabio Tumietto; Giuseppe Boriani; Pier Luigi Viale; Stefano Fanti; Claudio Rapezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-07       Impact factor: 9.236

7.  Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion.

Authors:  Ludivine Saby; Olivia Laas; Gilbert Habib; Serge Cammilleri; Julien Mancini; Laetitia Tessonnier; Jean-Paul Casalta; Frederique Gouriet; Alberto Riberi; Jean-Francois Avierinos; Frederic Collart; Olivier Mundler; Didier Raoult; Franck Thuny
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

Review 8.  The performance of quantitation methods in the evaluation of cardiac implantable electronic device (CIED) infection: A technical review.

Authors:  Matthew J Memmott; Jacqueline James; Ian S Armstrong; Deborah Tout; Fozia Ahmed
Journal:  J Nucl Cardiol       Date:  2015-09-25       Impact factor: 5.952

9.  Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.

Authors:  Michael T Osborne; Edward A Hulten; Avinainder Singh; Alfonso H Waller; Marcio S Bittencourt; Garrick C Stewart; Jon Hainer; Venkatesh L Murthy; Hicham Skali; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2013-12-03       Impact factor: 5.952
  9 in total
  1 in total

1.  In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction.

Authors:  Zhijun Pei; Jing Zeng; Yafeng Song; Yan Gao; Ruimin Wu; Yijia Chen; Fuyan Li; Wei Li; Hong Zhou; Yi Yang
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.